Early Conventional MRI for Prediction of Neurodevelopmental Impairment in Extremely-Low-Birth-Weight Infants.
Early Conventional MRI for Prediction of Neurodevelopmental Impairment in Extremely-Low-Birth-Weight Infants.
复制标题
作者:
Slaughter LA;Bonfante-Mejia E;Hintz SR;Dvorchik I;Parikh NA
Extremely low birth weight (ELBW, ≤1000g) infants are at high risk for neurodevelopmental impairments. Conventional brain MRI at term-equivalent age is increasingly used for prediction of outcomes. However, optimal prediction models remain to be determined, especially for cognitive outcomes. To evaluate the accuracy of a data-driven MRI scoring system to predict neurodevelopmental impairments. 122 ELBW infants had a brain MRI performed at term-equivalent age. Conventional MRI findings were scored with a standardized algorithm and tested using a multivariable regression model to predict neurodevelopmental impairment, defined as one or more of the following at 18–24 months corrected age: cerebral palsy, bilateral blindness, bilateral deafness requiring amplification, and/or cognitive/language delay. Results were compared with a commonly cited scoring system. In multivariable analyses, only moderate to severe gyral maturational delay was a significant predictor of overall neurodevelopmental impairment (Odds Ratio [OR]: 12.6, 95% CI: 2.6, 62.0; P<0.001). Moderate to severe gyral maturational delay also predicted cognitive delay, cognitive delay/death, and neurodevelopmental impairment/death. Diffuse cystic abnormality was a significant predictor of cerebral palsy (OR: 33.6, 95% CI: 4.9, 229.7; P<0.001). These predictors exhibited high specificity (range: 94% – 99%) but low sensitivity (30% – 67%) for the above outcomes. White or gray matter scores, determined using a commonly cited scoring system, did not show significant association with neurodevelopmental impairment. In our cohort, conventional MRI at term-equivalent age exhibited high specificity in predicting neurodevelopmental outcomes. However sensitivity was suboptimal, suggesting additional clinical factors and biomarkers are needed to enable accurate prognostication.
登录
查看更多内容
影响因子:
11.2
作者:
CHI, JG;DOOLING, EC;GILLES, FH
通讯作者:
GILLES, FH
影响因子:
8
作者:
Wilson-Costello, Deanne;Friedman, Harriet;Hack, Maureen
通讯作者:
Hack, Maureen
影响因子:
2.5
作者:
Mercier, Charles E.;Dunn, Michael S.;Soll, Roger F.
通讯作者:
Soll, Roger F.
影响因子:
158.5
作者:
Woodward, Lianne J.;Anderson, Peter J.;Inder, Terrie E.
通讯作者:
Inder, Terrie E.
影响因子:
8
作者:
Mirmiran, M;Barnes, PD;Ariagno, RL
通讯作者:
Ariagno, RL